Shares of Tempus AI ( TEM 14.71%) soared on Monday. The company's stock jumped 15% as of market close. The spike comes as the ...

Based on its analysis, Spruce Point stated that Tempus AI stock has the potential to fall about 50% to 60%. From the stock's ...

For context, Tempus uses AI to improve precision medicine solutions, as well as drug discovery and diagnostics. Its operating ...

Tempus AI Inc (NASDAQ:TEM) shares are moving higher Monday after the company introduced a new program to monitor ...

Tempus AI stock is trading at a nosebleed valuation, and despite the compelling long-term upside, it's not worth investing at ...

Tempus AI extended its winning streak to a third consecutive day on Monday, jumping 15.02 percent to close at $63.47 apiece ...

Tempus AI delivered strong Q1 results, driven by the Ambry Genetics acquisition and a major AstraZeneca contract, boosting ...

Shares of Tempus AI Inc (NASDAQ:TEM) surged 15% on Monday, recovering some of last week’s sharp losses after a short-seller report from Spruce Point Capital triggered a 13% weekly drop. The rebound ...

Shares of Tempus AI, Inc. (TEM) jumped 17% on Monday morning after the company announced a new liquid biopsy assay intended ...

Tempus AI, Inc. (NASDAQ:TEM), a leader in artificial intelligence for healthcare, has announced the launch of Fuses, a ...

Spruce Point's short report sent Tempus AI stock down 20%. TEM shares were overvalued and risky to own even without the short ...

BFLY outpaces TEM with stronger upside, leaner valuation, and expanding global reach in AI-powered diagnostics.